Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level
2021-12-21 08:04
European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
2021-12-21 03:28
Henlius' anti-PD-1 mAb MRCT achieved 15.38 months OS in first-line treatment of SCLC, reducing the risk of death by 38% of the overall population
2021-12-20 22:00
I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization
2021-12-20 21:00
2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices
2021-12-20 19:16
First Patient Dosed in Australia in ATG-101 First-in-Human Trial
2021-12-20 11:01
First Patient Dosed in Australia in ATG-101 First-in-Human Trial
2021-12-20 10:56
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
2021-12-20 08:24
Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma
2021-12-17 22:27
Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China
2021-12-17 19:00
Transcenta Announces the Appointment of Daniel Weng as CFO
2021-12-17 08:30
Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal
2021-12-17 05:16
Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index
2021-12-16 21:00
Bionomics Limited Announces Pricing of Initial Public Offering in the United States
2021-12-16 19:00
Antengene and XtalPi Announce AI-Driven R&D Collaboration
2021-12-16 16:30
BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021
2021-12-16 16:14
Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study
2021-12-16 16:00
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
2021-12-16 12:03
Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity
2021-12-16 08:30
Statement by WuXi AppTec Regarding Recent Market Fluctuation
2021-12-16 08:00
1
190
191
192
193
194
440